Bergen, Norway 4 April 2022
Demonstration of nano-scale dispensing of biochemical solutions on the Sencellchip and an article in the Norwegian Technical Weekly. Upcoming events and anoperational update.
Read more in the Lifecare April newsletter: https://lifecare.no/news/information-from-lifecare-april-2022/
This is Lifecare Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of bloodsugar in people with diabetes. The Company's patented technology also has thepotential for use in various biomarkers. Lifecare AS is listed on EuronextGrowth (LIFE).
Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.attme.dev,+47 40 05 90 40
This stock exchange announcement was published by Kine Hereid, InvestorRelations at Lifecare AS, on 04.04.22 at 09:00 CET.